Long before the pandemic began, people have been seeking more convenient and cost-effective healthcare than the traditional primary care or hospital care settings offer. COVID supercharged that need as the pandemic brought uncertainty about access combined with a fear of exposure to the virus. As a result, the opening in the traditional healthcare market has … Continued
In the early stages of the COVID pandemic, as most of the world sought hope amid soaring death tolls and sinking economies, a New Jersey company looked ahead and readied itself for the moment when a medical solution would arrive. Anticipating the development of vaccines as well as a red-hot worldwide demand for its products, Becton … Continued
As the official COVID-19 testing partner of USATF, tests using the BD Veritor™ Plus System will be conducted at several events throughout the Journey to Gold – Tokyo Outdoor Track & Field Series as athletes aim to qualify for the U.S. Olympic Team Trials – Track & Field.
As California moves away from the color-tiered system of restrictions in June and more COVID-19 vaccines end up in arms, businesses, event venues, and schools are looking to rapid testing as a solution for screening people frequently and reopening safely…
The MOT Charter School in Delaware is one of twenty schools participating in a state-wide program developed jointly by the Delaware Department of Education (DOE) and Delaware Health and Social Services (DHSS) to leverage testing to safely reopen schools by providing – at state expense – BD Veritor™ analyzers and SARS-CoV-2 (COVID-19) tests.
BD has received more than 1 billion orders for needles and syringes to support global COVID-19 vaccination planning efforts. Behind each injection device is a story – a frontline worker tirelessly providing life-saving care or an at-risk individual who has been waiting to see her grandson for the first time. Knowing the impact that our … Continued
Discover how BD and its employees are mobilizing to develop novel diagnostics, help ensure critical delivery of patient care and support the discovery of treatments in response to COVID-19.
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new molecular diagnostic test for both SARS-CoV-2 and Influenza A+B that can return results in two to three hours. The new test also has been CE … Continued
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the publication of a peer-reviewed study that shows BD’s antigen test may be more selective than PCR (polymerase chain reaction) molecular tests at detecting people who are contagious and able to spread COVID-19 disease. The study compared antigen and PCR test results … Continued
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that it has received pandemic orders for needles and syringes totaling more than 1 billion injection devices to support global COVID-19 vaccination planning efforts. This milestone reflects commitments from governments across the world, including the United States, Australia, Belgium, Canada, Germany, Netherlands, Saudi … Continued